SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Medical Oncology Consultation — Edward W. Brooke — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEdward W. Brooke
Date of birth1919-10-26
IdentifiersMRN HR-ML014-SYN-TD; SSN (made up) 000-14-5063
Document date2003-02-10
AuthorMei-Ling Cho, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Man of 83 with stage IIA, hormone receptor-positive, HER2-negative right breast cancer, fourteen weeks after bilateral mastectomy and right axillary dissection, on tamoxifen for eleven weeks, started at another hospital. Please take over his adjuvant endocrine therapy, confirm the adjuvant plan, and arrange germline genetic testing. [S]

Urgency: Routine, within four weeks. [S]

Questions for the consultant:

History of Present Illness

Mr. Brooke is seen at the request of Dr. Bellamy to take over his breast cancer care. He noticed discomfort in his right breast, which he dismissed for a time, before imaging and biopsy showed cancer; he says he did not know men could get breast cancer. He had a bilateral mastectomy and right axillary dissection at another hospital about four months ago, and started tamoxifen four weeks later. He has taken it daily for fifteen weeks with mild night hot flashes and no other effects. He has no bone pain, cough, headache, or weight loss. He is independent, walks most days, and has no history of blood clots, stroke, or liver disease. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Tamoxifen 20 mg oral tablet, one tablet by mouth once daily (adjuvant endocrine therapy, planned for at least five years)One tablet once dailyOral route2002-10-28activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route2003-02-10activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right male breast, central (retroareolar) portion, stage IIA (pT1c pN1a M0), grade 2, ER positive, PR positive, HER2 negative; treated by bilateral mastectomy and right axillary lymph node dissection; on adjuvant tamoxifen; synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.121S — Synthetic tumor size, grade, receptor status, and stage; the diagnosis, the right side, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
Long-term use of tamoxifen, with safety monitoring (venous thromboembolism, mood, hot flashes, sexual side effects, adherence) and bone health reviewactiveconfirmed Z79.810S — Synthetic adjuvant therapy in the modern episode.
Absence of both breasts after bilateral mastectomyactiveconfirmed Z90.13S — The double mastectomy is reported publicly (D); the coding is synthetic.

Physical Exam

Vital signs recorded on 2003-02-10; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell
Chest wallHealed transverse mastectomy scars on both sides; no nodule or skin change
Lymph nodesNo axillary, supraclavicular, or cervical nodes on either side
ExtremitiesUpper arm circumference 31 cm on both sides; no calf swelling or tenderness
AbdomenSoft; liver not enlarged

Results

DateMeasureValueUnitReference rangeFlagProvenance
2003-02-10DXA Femur [T-score] Bone density-1.2{T-score}-1.0 or higher is normal; -2.5 or lower is osteoporosisLowS
2003-02-10DXA Lumbar spine [T-score] Bone density-0.4{T-score}-1.0 or higher is normal; -2.5 or lower is osteoporosisNormalS
2003-02-10Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Assessment

Data reviewed: Outside imaging reports (bilateral diagnostic mammography and bilateral breast and axillary ultrasound), biopsy and surgical pathology with ER, PR, HER2, and Ki-67; the first-visit blood count, chemistry, and 25-hydroxyvitamin D; and the DXA scan from this morning (femoral neck T-score -1.2, lumbar spine -0.4). [S]

Plan of Treatment